Manufacturer
Sanofi S.p.A.
Contents
Per Maalox 4.3 mL oral susp Mg hydroxide 400 mg, Al hydroxide 460 mg
Indication
Gastrointestinal hyperacidity.
Instruction
Adult: 10-20 mL 4 times daily, given 20 minutes to 1 hour after meals and at bedtime or as required. Max: 80 mL per 24 hours.
Drug interaction
Interferes with the absorption of ciprofloxacin, chloroquine, hydroxychloroquine, chlorpromazine, cefdinir, cefpodoxime, ketoconazole, levothyroxine, rifampicin, rosuvastatin, tetracyclines, vitamins. May reduce the effect of polystyrene sulphonate. Decreased serum concentration of velpatasvir. Increased absorption with citrate-containing preparations. May decrease absorption of Fe salts.
Magnesium hydroxide: Increases the excretion of salicylates.
Sanofi S.p.A.
Contents
Per Maalox 4.3 mL oral susp Mg hydroxide 400 mg, Al hydroxide 460 mg
Indication
Gastrointestinal hyperacidity.
Instruction
Adult: 10-20 mL 4 times daily, given 20 minutes to 1 hour after meals and at bedtime or as required. Max: 80 mL per 24 hours.
Drug interaction
Interferes with the absorption of ciprofloxacin, chloroquine, hydroxychloroquine, chlorpromazine, cefdinir, cefpodoxime, ketoconazole, levothyroxine, rifampicin, rosuvastatin, tetracyclines, vitamins. May reduce the effect of polystyrene sulphonate. Decreased serum concentration of velpatasvir. Increased absorption with citrate-containing preparations. May decrease absorption of Fe salts.
Magnesium hydroxide: Increases the excretion of salicylates.
Inquiry - Maalox Oral Suspension in Sachet